US readiness assessment

Guided by a US Expert Advisory Group, the Radioligand Therapy Readiness Assessment Framework has been adapted and applied to the US health system. The resultant policy-focused situation analysis and policy blueprint aim to inform health system planning in the US.

These materials will be launched in late 2021 at a policy round table.